Soluble PTX3 of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Attenuates Hyperoxic Lung Injury by Activating Macrophage Polarization in Neonatal Rat Model

Therapeutic treatment of various inflammation-related diseases using mesenchymal stem cells (MSCs) has increased in recent years because of the paracrine action of these cells but shows several limitations. First, MSC-based therapies exhibit varying efficacies; thus, biomarkers should be determined...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Miyeon, Kwon, Ji Hye, Bae, Yun Kyung, Kim, Gee-Hye, Um, Soyoun, Ha, Jueun, Choi, Soo Jin, Oh, Wonil, Jin, Hye Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204119/
https://www.ncbi.nlm.nih.gov/pubmed/32399038
http://dx.doi.org/10.1155/2020/1802976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204119/
https://www.ncbi.nlm.nih.gov/pubmed/32399038
http://dx.doi.org/10.1155/2020/1802976

Ejemplares similares